EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Integrated 2D–3D Proteomic Profiling Identifies MLK4 as a Microenvironment‐Responsive Regulator of Chemotherapeutic Resistance in Human Glioblastoma Cells

Wannawat Khotchawan, Pakorn Ruengket iD, Pakpoom Kheolamai, Sith Sathornsumetee, Chomdao Sinthuvanich, Chanchao Lorthongpanich iD, Surapol Issaragrisil

Biology of the Cell · 2026-05 · 118 (5)

DOI: 10.1111/boc.70068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of the Cell, online erschienen am 01.05.2026. Verfasst von Wannawat Khotchawan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Siriraj Center of Excellence for Stem Cell Research (SiSCR), Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Glioblastoma, Drug Resistance, Neoplasm, Proteomics, Tumor Microenvironment. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Council of Thailand, Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Therapeutic resistance is a major cause of treatment failure in glioblastoma (GBM), highlighting the need for physiologically relevant models to identify actionable resistance mechanisms. While two‐dimensional (2D) cultures are widely used for target discovery, they poorly represent the tumor microenvironment. In contrast, three‐dimensional (3D) spheroid cultures better recapitulate spatial heterogeneity, hypoxic gradients, and stress‐adaptive signaling observed in tumors.

Methods

We applied an integrated 2D–3D quantitative proteomic approach to identify microenvironment‐dependent regulators of chemoresistance in GBM. Proteomic profiling was performed in U87MG and U251MG cells grown as 2D monolayers or 3D spheroids. Differentially expressed proteins were validated by quantitative RT‐PCR, and functional studies were conducted using genetic depletion followed by assessment of temozolomide (TMZ) sensitivity.

Results

Comparative analysis identified 13 proteins consistently differentially expressed between 2D and 3D cultures: NDUFB5, RNGTT, MLK4, SYN1, DDX5, EIF2AK2, ITGA1, ZNF33B, ZNF343, WDR19, JPH3, CCT8L2, and FNDC3A. Among these, Mixed Lineage Kinase 4 (MLK4) showed strong and reproducible upregulation in 3D spheroids in both GBM cell lines. Genetic depletion of MLK4 significantly increased TMZ sensitivity without affecting basal cell viability, suggesting a specific role in therapy response. Notably, MLK4 expression was induced only under 3D conditions.

Conclusion

MLK4 functions as a microenvironment‐responsive regulator of chemoresistance in GBM. These findings demonstrate that 3D culture systems reveal clinically relevant resistance pathways not detectable in conventional 2D models and highlight 3D proteomic profiling as a powerful strategy for identifying therapeutically actionable targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaDrug Resistance, NeoplasmProteomicsTumor MicroenvironmentBrain NeoplasmsHumansCell Line, TumorTemozolomideGene Expression Regulation, NeoplasticDacarbazineSpheroids, Cellular

Stichwörter der Autor:innen

3D Cell CultureMLK4glioblastomaproteomicstemozolomide

Substanzen

TemozolomideDacarbazine

Autor:innen und Institutionen

  • Siriraj Center of Excellence for Stem Cell Research (SiSCR), Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok, Thailand.
  • Division of Cell Biology, Faculty of Medicine, Thammasat University, Bangkok, Thailand.
  • Center of Excellence in Stem Cell Research and Innovation, Faculty of Medicine, Thammasat University, Bangkok, Thailand.
  • Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Blood Products and Cellular Immunotherapy Research Group, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Pakorn Ruengket, Chanchao Lorthongpanich

Förderung

  • National Research Council of Thailand
  • Mahidol University

Zitieren

APA

Khotchawan, W., Ruengket, P., Kheolamai, P., Sathornsumetee, S., Sinthuvanich, C., Lorthongpanich, C., & Issaragrisil, S. (2026). Integrated 2D–3D Proteomic Profiling Identifies MLK4 as a Microenvironment‐Responsive Regulator of Chemotherapeutic Resistance in Human Glioblastoma Cells. Biology of the Cell, 118(5). https://doi.org/10.1111/boc.70068

Vancouver

Khotchawan W, Ruengket P, Kheolamai P, Sathornsumetee S, Sinthuvanich C, Lorthongpanich C, et al. Integrated 2D–3D Proteomic Profiling Identifies MLK4 as a Microenvironment‐Responsive Regulator of Chemotherapeutic Resistance in Human Glioblastoma Cells. Biology of the Cell. 2026;118(5). doi:10.1111/boc.70068

BibTeX
@article{Khotchawan2026,
  author = {Khotchawan, Wannawat and Ruengket, Pakorn and Kheolamai, Pakpoom and Sathornsumetee, Sith and Sinthuvanich, Chomdao and Lorthongpanich, Chanchao and Issaragrisil, Surapol},
  title = {Integrated 2D–3D Proteomic Profiling Identifies MLK4 as a Microenvironment‐Responsive Regulator of Chemotherapeutic Resistance in Human Glioblastoma Cells},
  journal = {Biology of the Cell},
  year = {2026},
  volume = {118},
  number = {5},
  doi = {10.1111/boc.70068}
}
Kostenlos starten →